viewCapstone Turbine Corporation

Capstone Turbine sponsors another Indy car to promote renewable energy

Capstone partnered with Gess International (Green Energy Sustainable Solutions) to co-sponsor the No. 27 car at Texas Motor Speedway and Pocono Raceway

Indy car no. 27
The green and white No. 27 GESS/Capstone Honda will be driven by Alexander Rossi

Capstone Turbine Corporation (NASDAQ:CPST) announced Wednesday it will sponsor another Indy race car as part of its ongoing campaign to highlight the promise of renewable energy.

Capstone is again partnering with biogas producer GESS International (Green Energy Sustainable Solutions Inc) of North Carolina to sponsor the Andretti Autosport No. 27 Indy race car at the Texas Motor Speedway and the “Tricky Triangle” of Pocono Raceway.

The green and white No. 27 GESS/Capstone Honda driven by Alexander Rossi will hit the Texas Motor Speedway in Forth Worth on Sunday evening under the lights on the 1.5-mile oval track. Pocono Raceway in Long Pond, Pennsyalvania will host the ABC Supply 500 on August 18.

READ: Capstone Turbine caps a wave of good news with Indy 500 sponsorship

Both companies last month co-sponsored the #88 Honda Indy car driven by 19-year-old rookie Colton Herta at the Indianapolis 500 to foster awareness of biogas and renewable natural gas as the fuel of the future to combat climate change.

“I’m confident that our sponsorship with the world-renowned Andretti Autosport will help us raise awareness of our clean energy technology,” said Capstone CEO Darren Jamison.

Capstone, based in Van Nuys, California, offers a product lineup of microturbines that can produce anywhere from 30 kilowatts to 10 megawatts of power, operating on a variety of gaseous or liquid fuels. To date, Capstone has shipped over 9,000 units to 73 countries.

The company's stock recently traded up 0.36% to $0.85 a share.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Capstone Turbine Corporation

Price: 2.97 USD

Market: NASDAQ
Market Cap: $32.62 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Genprex reveals slew of recent milestones as it plans for upcoming clinical...

Genprex Inc (NASDAQ:GNPX) CEO Rodney Varner talks to Proactive's Christine Corrado about the Texas-based biotechnology company's most recent updates. Namely, Varner says the firm has approved the generic name quaratusugene ozeplasmid, for its non-small cell lung cancer drug formerly known as...

17 hours, 17 minutes ago

2 min read